Skip to content
New platform coming soon — AI-Based Analysis with Human-Generated Insights
Stock Target Advisor Stock Target Advisor Market intelligence
  • Research ▾
    • Equity Reports
    • STA Portfolio
    • Top Stocks
  • Market Analysis
  • Analyst Ratings
  • Stock Research Tools ▾
    • Analyst Target Tool
    • Analyst Ranking Tool
    • Stock Analysis Tool
  • About ▾
    • About STA
    • Services
    • Contribute
    • Contact
  • Social Media ▾
    • YouTube
    • Blossom
    • Substack
    • TikTok

Browse research

Tag: Earnings

BCE-Inc. (BCE:CA) TD Securities Raises Target to $44.00
Market News & Insights Nov 6, 2024

Is BCE Inc’s Stock a “Buy” after the Fall?

BCE Inc. (BCE:CA) (BCE) BCE Inc’s stock is currently in a bearish phase, having fallen by nearly 12.76% over the past month…

#Canadian Markets #Dividends #Earnings
https://www.stocktargetadvisor.com/Stock-Screener
Market News & Insights Nov 6, 2024

What’s The Best Portfolio For a Trump Presidency?

Stocks/ETFs to Consider A Trump presidency could impact markets and sectors in particular ways based on policies he has previously supported, though…

#banking #Earnings #energy stocks
Market News & Analysis: November 19th
Market News & Insights Nov 6, 2024

Market News & Analysis: November 6th, 2024

Global Markets North American Markets Canada’s TSX rose on the back of global market momentum as news broke that Donald Trump had…

#Artificial Intelligence #Canadian Markets #Earnings
Boyd Group Services stock, BYD:CA, Joe Hudson’s Collision Center acquisition, Boyd Group expansion, Boyd stock forecast, collision repair industry, TSX industrial stocks, Boyd Group price target, auto repair market growth, Boyd Group analysts rating
Market News & Insights Nov 6, 2024

Boyd Group Services: AI Analysis Predicts 30% Upside Potential

Boyd Group Services Inc (BYD:CA) has emerged as a compelling investment opportunity on the TSX, with a current trading price of CAD…

#analyst ratings #Artificial Intelligence #Canadian Markets
Teva Pharma Industries Ltd
Market News & Insights Nov 6, 2024

Teva Pharma Q3 2024: Revenue Growth and Strategic Wins Propel Financial Outlook

Teva Pharmaceutical Industries Ltd (TEVA) recently announced robust financial results for Q3 2024, showcasing substantial growth in its generic and innovative product…

#Earnings #energy stocks #etfs

Posts pagination

Previous 1 … 342 343 344 345 346 … 671 Next
Stock Target Advisor

Timely market news, analyst rating changes, and practical investment research for investors around the world.

  • Research
  • Analyst Ratings
  • Market Analysis
  • Top Stocks
  • About Us
  • Contact Us
  • Contribute a Post
© 2026 Stock Target Advisor. All rights reserved.

STA RESEARCH

Get the STA Research Professional Newsletter

Market outlook, portfolio updates, technical analysis and stock ideas—US$5/month.

See What’s Included →

Monthly subscription. Secure checkout with PayPal.